Loading NexProTools...
Preparing interactive calculation engine
Preparing interactive calculation engine
Compare Apolipoprotein B (ApoB) particle count against LDL Cholesterol (LDL-C) mass concentration to uncover hidden cardiovascular plaque risk.
Side-by-side analytical breakdown
| Comparison Metric | ApoB Cardiovascular Risk Matrix | Blood Biomarker Longevity Interpreter | Advantage |
|---|---|---|---|
| Measurement Metric | Physical Particle Count (ApoB-100) | Cholesterol Mass (mg/dL) | ApoB Cardiovascular Risk Matrix |
| sdLDL Discordance Detection | 100% Accurate (Every particle = 1 ApoB) | Fails in Insulin Resistance | ApoB Cardiovascular Risk Matrix |
| ESC Optimal Longevity Target | < 60 mg/dL (or < 50 mg/dL secondary) | < 70 mg/dL (or < 55 mg/dL secondary) | Balanced Choice |
| Genetic Causality (Mendelian) | Direct Plaque Particle Driver | Indirect Mass Surrogate | ApoB Cardiovascular Risk Matrix |
Deterministic Mathematical Simulation Engine • Client-Side Computation
Evaluate exact atherogenic lipoprotein particle counts, identify ApoB vs LDL-C discordance, and calculate clinical lipid targets based on ESC and NLA guidelines.
| Parameter | Value | Unit |
|---|---|---|
| Apolipoprotein B (ApoB) | 95 | mg/dL |
| LDL Cholesterol | 120 | mg/dL |
| Metric | Calculated Output |
|---|---|
| Cardiovascular Risk Tier | Optimal Cardiometabolic Profile (< 80 mg/dL) |
Deterministic Mathematical Simulation Engine • Client-Side Computation
Interpret routine blood panels against optimal longevity reference ranges. Calculate HOMA-IR insulin resistance, hs-CRP inflammation, HbA1c, and ferritin.
| Parameter | Value | Unit |
|---|---|---|
| Fasting Glucose | 88 | mg/dL |
| Fasting Insulin | 6.5 | uIU/mL |
| Metric | Calculated Output |
|---|---|
| HOMA-IR Score | 1.41 |
LDL-C measures only the mass weight of cholesterol carried within LDL particles, whereas ApoB directly counts every single circulating atherogenic vehicle (LDL, VLDL, IDL, Lp(a)). In patients with insulin resistance, high triglycerides, or diabetes, particles become cholesterol-depleted and small, meaning LDL-C looks deceptively normal while dangerous ApoB particle numbers remain critically elevated.
Clinical guidelines from the European Society of Cardiology (ESC) and National Lipid Association (NLA) recognize ApoB as the superior cardiovascular risk predictor because cardiovascular plaque formation is driven by particle count rather than total cholesterol weight.